Thus, FRs could act by several distinct pathways causing biochemical disruption and leading to NAFLD and progression to NASH and eventually HCC particularly via modulation of NRs, ROS production, lipid peroxidation, cytokine release, insulin resistance, and mitochondrial dysfunction, as outlined in Figure 4. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.